PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 133 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $106,000 | +606.7% | 27,938 | +767.6% | 0.00% | – |
| Q4 2019 | $15,000 | +275.0% | 3,220 | +241.1% | 0.00% | – |
| Q3 2019 | $4,000 | +33.3% | 944 | +112.6% | 0.00% | – |
| Q2 2019 | $3,000 | +50.0% | 444 | -15.3% | 0.00% | – |
| Q1 2019 | $2,000 | -33.3% | 524 | -40.4% | 0.00% | – |
| Q4 2018 | $3,000 | -90.0% | 879 | -80.6% | 0.00% | – |
| Q3 2018 | $30,000 | 0.0% | 4,530 | +25.3% | 0.00% | – |
| Q2 2018 | $30,000 | +25.0% | 3,616 | +17.6% | 0.00% | – |
| Q1 2018 | $24,000 | +71.4% | 3,074 | +34.9% | 0.00% | – |
| Q4 2017 | $14,000 | -70.2% | 2,279 | -64.0% | 0.00% | – |
| Q3 2017 | $47,000 | +683.3% | 6,338 | +659.0% | 0.00% | – |
| Q2 2017 | $6,000 | -53.8% | 835 | -35.1% | 0.00% | – |
| Q1 2017 | $13,000 | -62.9% | 1,286 | -68.1% | 0.00% | – |
| Q4 2016 | $35,000 | +3400.0% | 4,027 | +819.4% | 0.00% | – |
| Q2 2016 | $1,000 | -80.0% | 438 | -59.0% | 0.00% | – |
| Q1 2016 | $5,000 | -92.5% | 1,067 | -90.3% | 0.00% | – |
| Q4 2015 | $67,000 | -69.7% | 10,968 | -71.6% | 0.00% | – |
| Q3 2015 | $221,000 | – | 38,687 | +110434.3% | 0.00% | – |
| Q2 2015 | $0 | -100.0% | 35 | -88.3% | 0.00% | – |
| Q1 2015 | $2,000 | -66.7% | 300 | -60.0% | 0.00% | – |
| Q4 2014 | $6,000 | +200.0% | 750 | +150.0% | 0.00% | – |
| Q3 2014 | $2,000 | +100.0% | 300 | -15.5% | 0.00% | – |
| Q2 2014 | $1,000 | 0.0% | 355 | +18.3% | 0.00% | – |
| Q1 2014 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | – |
| Q4 2013 | $2,000 | -66.7% | 300 | -73.4% | 0.00% | – |
| Q3 2013 | $6,000 | +500.0% | 1,127 | +275.7% | 0.00% | – |
| Q2 2013 | $1,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|